Prevalence and risk factors of polycystic ovary syndrome among reproductive-aged women

Hasina Khatun; Reefaat Rahman; Tanzila Halim; Amena Khan; M. Mehedi Hasan

doi:10.18203/2320-1770.ijrcog20250847

Authors

Hasina Khatun Department of Obstetrics and Gynecology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Reefaat Rahman Department of Obstetrics and Gynecology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Tanzila Halim Department of Obstetrics and Gynecology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Amena Khan Department of Obstetrics and Gynecology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
M. Mehedi Hasan Department of Epidemioloy, DG Health, Directorate General of Health Service, Dhaka, Bangladesh

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20250847

Keywords:

Baldness, Menstrual irregularities, Polycystic ovary syndrome, Prevalence, Risk factors

Abstract

Background: PCOS is one of the most common reproductive and hormonal health issues that Bangladeshi women and young girls’ experience, yet many remain unaware of their condition until later in life. This study assessed the prevalence of and examined the factors of polycystic ovary syndrome (PCOS) among reproductive-aged women.

Methods: This study cross-sectional included 500 patients diagnosed with PCOS who visited the department of obstetrics and gynecology, BSMMU, Dhaka, Bangladesh. This 2-years-long study included reproductive-aged women who were suffering from PCOS. Data were collected using a structured questionnaire that was administered to participants. The prevalence percentage of physician-diagnosed PCOS was calculated. A multivariable logistic regression model was employed to determine the adjusted odds ratios (aOR) and the corresponding 95% confidence intervals (CI) for the factors significantly associated with PCOS status.

Results: Out of the 500 participants, the majority were single (85%), and the age group of 21 to 25 years comprised 56% of the participants. The prevalence of polycystic ovary syndrome (PCOS) was found to be 61% out of 500 participants affected. The risk factors that were significantly associated with PCOS included. Menstrual irregularities [adjusted odds ratio (aOR) =7.67; 95% confidence interval (CI): 3.72-15.83], family history of PCOS (aOR =5.11; 95% CI: 2.32-11.31), Hirsutism (aOR=3.55; 95% CI: 2.06-6.21) and Male pattern baldness (aOR=2.06; 95% CI: 1.19-3.58).

Conclusions: This study revealed a moderately high prevalence of PCOS. Menstrual irregularities, obesity, a family history of PCOS, hirsutism, and baldness were significantly associated with the status of PCOS in the study sample.

Metrics

Metrics Loading ...

References

Chang S, Dunaif A. Diagnosis of polycystic ovary syndrome: Which criteria to use and when? Endocrinol Metab Clin North Am. 2021;50(1):11-23. DOI: https://doi.org/10.1016/j.ecl.2020.10.002

Group REA-PC. Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19-25 DOI: https://doi.org/10.1016/j.fertnstert.2003.10.004

Ndefo UA, Eaton A, Green MR. Polycystic ovary syndrome: A review of treatment options with a focus on pharmacological approaches. Pharm Therap. 2013;38(6):336-55.

Daniilidis A, Dinas K. Long term health consequences of polycystic ovarian syndrome: a review analysis. Hippokratia. 2009;13(2):90-2.

Jabeen A, Yamini V, Amberina AR, Eshwar MD, Vadakedath S, Begum GS, et al. Polycystic ovarian syndrome: prevalence, predisposing factors, and awareness among adolescent and young girls of South India. Cureus. 2022;14(8). DOI: https://doi.org/10.7759/cureus.27943

Ding T, Hardiman PJ, Petersen I, Wang FF, Qu F, Baio G. The prevalence of polycystic ovary syndrome in reproductive-aged women of different ethnicity: a systematic review and meta-analysis. Oncotarget. 2017;8(56):96351. DOI: https://doi.org/10.18632/oncotarget.19180

Mousa M, Al-Jefout M, Alsafar H, Kirtley S, Lindgren CM, Missmer SA, et al. Prevalence of common gynecological conditions in the middle east: systematic review and meta-analysis. Front Reprod Health. 2021;3:661360. DOI: https://doi.org/10.3389/frph.2021.661360

Musmar S, Afaneh A, Mo’alla H. Epidemiology of polycystic ovary syndrome: a cross sectional study of university students at An-Najah National University- Palestine. Reprod Biol Endocrinol. 2013;11:47. DOI: https://doi.org/10.1186/1477-7827-11-47

Shinde KS, Patil SS. Incidence and risk factors of polycystic ovary syndrome among women in reproductive age group attending a tertiary health care hospital in Western Maharashtra. Int J Reprod Contracept Obstet Gynecol. 2019;8(7):2804. DOI: https://doi.org/10.18203/2320-1770.ijrcog20193046

Alkhezi F, AlNemash N, AlMutairi J, Saleh S, AlMutairi M, Saleh S, et al. Prevalence of and risk factors associated with polycystic ovary syndrome among female university students of health sciences in a Middle Eastern country. Women’s Health Rep. 2024;5(1):579-87. DOI: https://doi.org/10.1089/whr.2023.0176

Choudhary A, Jain S, Chaudhari P. Prevalence and symptomatology of polycystic ovarian syndrome in Indian women: Is there a rising incidence? Int J Reprod Contracept Obstet Gynecol. 2017;6(11):4971. DOI: https://doi.org/10.18203/2320-1770.ijrcog20175010

Azziz R, Carmina E, Chen Z, Dunaif A, Laven JS, Legro RS, et al. Polycystic ovary syndrome. Nat Rev Dis Prim. 2016;2(1):1-8. DOI: https://doi.org/10.1038/nrdp.2016.57

Aldossary K, Alotaibi A, Alkhaldi K, Alharbi R. Prevalence of polycystic ovary syndrome, and relationship with obesity/overweight: cross-sectional study in Saudi Arabia. J Adv Pharm Educ Res. 2020;10(1):186-90.

Asuncion M, Calvo RM, San Millán JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab. 2000;85(7):2434-8. DOI: https://doi.org/10.1210/jc.85.7.2434

Wolf WM, Wattick RA, Kinkade ON, Olfert MD. Geographical prevalence of polycystic ovary syndrome as determined by region and race/ethnicity. Int J Environ Res Public Health. 2018;15(11):2589. DOI: https://doi.org/10.3390/ijerph15112589

Tehrani FR, Simbar M, Tohidi M, Hosseinpanah F, Azizi F. The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study. Reprod Biol Endocrinol. 2011;9:1-7. DOI: https://doi.org/10.1186/1477-7827-9-39

Mehrabian F, Khani B, Kelishadi R, Ghanbari E. The prevalence of polycystic ovary syndrome in Iranian women based on different diagnostic criteria. Endokrynol Polska. 2011;62(3):238-42.

Kumarapeli V, Seneviratne RD, Wijeyaratne CN, Yapa RM, Dodampahala SH. A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semiurban population in Sri Lanka. Am J Epidemiol. 2008;168(3):321-8. DOI: https://doi.org/10.1093/aje/kwn137

Park YJ, Shin H, Jeon S, Cho I, Kim YJ. Menstrual cycle patterns and the prevalence of premenstrual syndrome and polycystic ovary syndrome in korean young adult women. Healthcare (Switzerland). 2021;9(1):56. DOI: https://doi.org/10.3390/healthcare9010056

Chin HB, Marsh EE, Hall JE, Baird DD. Prevalence of hirsutism among reproductive-aged African American women. J Women’s Health. 2021;30(11):1580-7. DOI: https://doi.org/10.1089/jwh.2021.0125

Huei LT, Badaruddin NS, Phd PM. Prevalence and psychosocial impact of acne vulgaris among high school and university students in Sarawak, Malaysia. Med J Malaysia. 2022;77(4):446-53.

Carmina E, Dreno B, Lucky WA. Female adult acne and androgen excess: a report from the multidisciplinary androgen excess and PCOS committee. J Endocr Soc. 2022;6(3):bvac003. DOI: https://doi.org/10.1210/jendso/bvac003

Davoudi Z, Araghi F, Vahedi M, Mokhtari N, Gheisari M. Prolactin level in polycystic ovary syndrome (PCOS): an approach to the diagnosis and management. Acta Biomed. 2021;92(5):e2021291.

Filho RB, Domingues L, Naves L. Polycystic ovary syndrome and hyperprolactinemia are distinct entities. Gynecol Endocrinol. 2007;23(5):267-72. DOI: https://doi.org/10.1080/09513590701297708

Kyritsi EM, Dimitriadis GK, Angelousi A, Mehta H, Shad A, Mytilinaiou M, et al. The value of prolactin in predicting prolactinoma in hyperprolactinaemic polycystic ovarian syndrome. Eur J Clin Invest. 2018;48(7):e12961. DOI: https://doi.org/10.1111/eci.12961

Nair MK, Pappachan P, Balakrishnan S, Leena ML, George B, Russell PS. Menstrual irregularity and poly cystic ovarian syndrome among adolescent girls- a 2 year follow-up study. Indian J Pediatr. 2012;79:69-73. DOI: https://doi.org/10.1007/s12098-011-0432-y

Azziz R, Kashar-Miller MD. Family history as a risk factor for the polycystic ovary syndrome. J Pediatr Endocrinol Metab 2000;13(5):1303-6.

Clayton RN, Ogden V, Hodgkinson J. How common are polycystic ovaries in normal women and what is their significance for the fertility of the population? Clin Endocrinol. 1992;37(2):127-34. DOI: https://doi.org/10.1111/j.1365-2265.1992.tb02296.x

Chang RJ, Nakamura RM, Judd HL, Kaplan SA. Insulin resistance in nonobese patients with polycystic ovarian disease. J Clin Endocrinol Metab. 1983;57(2):356-9. DOI: https://doi.org/10.1210/jcem-57-2-356

Özdemir S, Özdemir M, Görkemli H, Kiyici A, Bodur S. Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism. Acta Obstet Gynecol Scand. 2010;89(2):199-204. DOI: https://doi.org/10.3109/00016340903353284

Cela E, Robertson C, Rush K, Kousta E, White DM, Wilson H, et al. Prevalence of polycystic ovaries in women with androgenic alopecia. Eur J Endocrinol. 2003;149(5):439-42. DOI: https://doi.org/10.1530/eje.0.1490439